Dreem, a Paris, France- and San Francisco-based neurotechnology company, closed a $35m funding.
The round was led by strategic investor Johnson & Johnson Innovation and Bpifrance.
The company, which has raised nearly $60m in less than four years, intends to use the funds to accelerate product development, invest in strategic research and development, and advance the future of sleep technology.
Led by Hugo Mercier, CEO, Dreem recently introduced a comprehensive solution to address a suite of sleep problems and enhance the quality of rest during the night. The company’s headband monitors brain activity to track sleep accurately and uses auditory stimulation as a medium to help people fall asleep faster, get deeper sleep, and wake up refreshed.
Dreem, which has a team of more than 70 people, previously raised a total of $22m, from Xavier Niel, Dr. Laurent Alexandre, and MAIF.